PHASE I DOSE-ESCALATION TRIAL OF MULTIPLE AND FRACTIONATED-DOSE PSMA-TARGETED ALPHA RADIONUCLIDE (225AC-J591) FOR METASTATIC CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Sun, Michael
Nauseef, Jones
Fajardo, Andres Ricaurte
Davidson, Zachary
Thomas, Joseph
Ruder, Samuel
Stangl-Kremser, Judith
Castellanos, Sandra Huicochea
Molina, Ana
Sternberg, Cora
Patel, Amie
Yuan, Sarah
Fernandez, Escarleth
Fung, Edward
Avlonitis, Vasilios
O'Dwyer, Elisabeth
Nanus, David
Osborne, Joseph
Bander, Neil
Tagawa, Scott
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
关键词：
D O I：
10.1097/01.JU.0001009540.33579.43.11
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD01-11
引用
收藏
页码：E67 / E68
页数：2
相关论文
共 50 条
  • [31] PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Kratochwil, Clemens
    Giesel, Frederik L.
    Stefanova, Melsa
    Benesova, Martina
    Bronzel, Marcus
    Afshar-Oromieh, Ali
    Mier, Walter
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) : 1170 - 1176
  • [32] Final results of phase I/II trial of fractionated dose 177Lu-PSMA-617 for metastatic castration-resistant prostate cancer (mCRPC)
    Tagawa, S. T.
    Sun, M.
    Sartor, O.
    Thomas, C.
    Molina, A. M.
    Sternberg, C. N.
    Nanus, D. M.
    Osborne, J.
    Bander, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S645 - S645
  • [33] [225Ac]Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer: efficacy and treatment outcome
    Ebrahimifard, A.
    Bagheri, S.
    Wang, Q.
    Eilsberger, F.
    Luster, M.
    Librizzi, D.
    Yousefi, B. H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S360 - S360
  • [34] Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
    Madan, Ravi A.
    Mohebtash, Mahsa
    Arlen, Philip M.
    Vergati, Matteo
    Rauckhorst, Myrna
    Steinberg, Seth M.
    Tsang, Kwong Y.
    Poole, Diane J.
    Parnes, Howard L.
    Wright, John J.
    Dahut, William L.
    Schlom, Jeffrey
    Gulley, James L.
    LANCET ONCOLOGY, 2012, 13 (05): : 501 - 508
  • [35] ASSESSMENT OF PSMA PET IMAGING RESPONSE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AFTER 225AC-J591 THERAPY: POST-HOC PATIENT-LEVEL ANALYSIS OF A PROSPECTIVE CLINICAL TRIAL
    Ricaurte-Fajardo, Andres
    Martinez-Fundichel, Alexander
    Castellanos, Sandra Huicochea
    Sun, Michael
    Tagawa, Scott
    Bander, Niel H.
    Osborne, Joseph R.
    Stangl-Kremser, Judith
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S103 - S103
  • [36] 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients
    Yadav, Madhav
    Ballal, Sanjana
    Tripathi, Madhavi
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [37] Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings
    Hummel, Horst-Dieter
    Kufer, Peter
    Gruellich, Carsten
    Seggewiss-Bernhardt, Ruth
    Deschler-Baier, Barbara
    Chatterjee, Manik
    Goebeler, Maria-Elisabeth
    Miller, Kurt
    de Santis, Maria
    Loidl, Wolfgang
    Dittrich, Christian
    Buck, Andreas
    Lapa, Constantin
    Thurner, Annette
    Wittemer-Rump, Sabine
    Koca, Gokben
    Boix, Oliver
    Doecke, Wolf-Dietrich
    Finnern, Ricarda
    Kusi, Helena
    Ajavon-Hartmann, Antoinette
    Stienen, Sabine
    Sayehli, Cyrus Michael
    Polat, Buelent
    Bargou, Ralf C.
    IMMUNOTHERAPY, 2021, 13 (02) : 125 - 141
  • [38] Fractionated dose radiolabeled anti-prostate specific membrane antigen (PSMA) radioimmunotherapy (177Lu-J591) for progressive metastatic castration-resistant prostate cancer (mCRPC).
    Batra, Jaspreet S.
    Karir, Beerinder S.
    Pinto-Chengot, Kavya
    Jhanwar, Yuliya
    Vallabhajosula, Shankar
    Christos, Paul J.
    Hodes, Gillian
    Lam, Linda
    Molina, Ana M.
    Beltran, Himisha
    Nanus, David M.
    Goldsmith, Stanley J.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [39] Phase I Dose-Escalation Study of the Novel Antiandrogen BMS-641988 in Patients with Castration-Resistant Prostate Cancer
    Rathkopf, Dana
    Liu, Glenn
    Carducci, Michael A.
    Eisenberger, Mario A.
    Anand, Aseem
    Morris, Michael J.
    Slovin, Susan F.
    Sasaki, Yasutsuna
    Takahashi, Shunji
    Ozono, Seiichiro
    Fung, Nga Kit Eliza
    Cheng, Shinta
    Gan, Jinping
    Gottardis, Marco
    Obermeier, Mary T.
    Reddy, Jyotsna
    Zhang, Steven
    Vakkalagadda, Blisse J.
    Alland, Leila
    Wilding, George
    Scher, Howard I.
    CLINICAL CANCER RESEARCH, 2011, 17 (04) : 880 - 887
  • [40] Phase I dose-escalation and pharmacokinetic study (TED 11576) of cabazitaxel in Japanese patients with castration-resistant prostate cancer
    Mukai, Hirofumi
    Takahashi, Shunji
    Nozawa, Masahiro
    Onozawa, Yusuke
    Miyazaki, Jun
    Ohno, Keiji
    Suzuki, Kazuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 703 - 710
12345